prostate cancer

January 5, 2015

Vanderbilt-led team studies blood test for prostate cancer

Vanderbilt University researcher William Mitchell, M.D., Ph.D., and colleagues in Germany and Canada have demonstrated a method for detecting “cell-free” tumor DNA in the bloodstream.

By Bill Snyder
October 29, 2014

Key to prostate cancer resistance

A combination of two types of therapy may be more effective in treating castration-resistant prostate cancer.

By VUMC News and Communications
April 3, 2014

Protein’s role in spread of colon cancer studied

One of the most formidable weapons in a cancer’s arsenal is the ability to spread to other organs.

By VUMC News and Communications
March 27, 2014

Study links stem cell gene to prostate cancer susceptibility

A gene on chromosome 8 — in a region of the genome linked to risk for many types of cancer — is particularly associated with prostate cancer susceptibility, Vanderbilt University researchers have found.

By Leigh MacMillan
Andries Zijlstra, Ph.D., and colleagues are studying a biomarker that can help predict prostate cancer recurrance. (photo by Susan Urmy)
December 5, 2013

Predictor of prostate cancer outcomes identified

Researchers at Vanderbilt University Medical Center and the University of Alberta in Canada have identified a biomarker for a cellular switch that accurately predicts which prostate cancer patients are likely to have their cancer recur or spread.

By VUMC News and Communications
May 23, 2013

VU to lead prostate cancer treatment research effort

David Penson, M.D., MPH, professor of Urologic Surgery, has received a $2 million research award from the Patient-Centered Outcomes Research Institute (PCORI) to study localized prostate cancer, the second leading cause of death among American men.

By VUMC News and Communications
January 30, 2013

Long-term effects of prostate therapies tracked

A new study comparing outcomes among prostate cancer patients treated with surgery versus radiotherapy found differences in urinary, bowel and sexual function after short-term follow-up, but those differences were no longer significant 15 years after initial treatment.
By VUMC News and Communications
November 15, 2012

Study tracks antioxidants’ role in prostate tumor growth

Antioxidants promote cell growth in a mouse model of prostate cancer, Vanderbilt researchers report in the journal PLoS ONE. The findings provide insight into the recent controversy regarding antioxidants and prostate cancer prevention.
By Leigh MacMillan
August 30, 2012

Vanderbilt-led study reveals racial disparities in prostate cancer care

Racial differences exist in quality surgical care, new research from VICC finds.
By VUMC News and Communications
August 23, 2012

Gene linked to familial prostate cancer

A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows.
By VUMC News and Communications
August 2, 2012

Proteins may point way to new prostate cancer drug targets

Two proteins that act in opposing directions – one that promotes cancer and one that suppresses cancer — regulate the same set of genes in prostate cancer, Vanderbilt-Ingram Cancer Center researchers have found.
By VUMC News and Communications
July 24, 2012

Proteins guard against cancer spread

Targeting immune system proteins may keep prostate cancer from spreading to bone.
By VUMC News and Communications
February 22, 2011

Protein ‘scissors’ cut path for cancer

The protein matriptase "cuts" a key component of the prostate tissue barrier and may be involved in prostrate cancer progression, new research finds.
By Leigh MacMillan
1 2 3 4 5